MARSHALL WACE, LLP

Position in EDIT — Editas Medicine, Inc.

CIK 1318757 LONDON, X0

Position in EDIT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,600,809

+$6,081,349 QoQ

Shares Held

2,037,287

+868.7% QoQ

Ownership

1.33%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#18

of 216 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. EDIT ranks #83 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,600,809	2,037,287	+868.7%	Shares	Other	2026-08-13
2026-03-31	$519,460	210,308	+48.1%	Shares	Other	2026-05-15
2025-06-30	$312,416	142,008	-41.4%	Shares	Other	2025-08-13
2025-03-31	$281,155	242,376	+280.1%	Shares	Other	2025-05-15
2024-09-30	$217,418	63,759	-85.8%	Shares	Other	2024-11-14
2024-06-30	$2,097,543	449,153	-43.2%	Shares	Other	2024-08-14
2024-03-31	$5,871,594	791,320	-28.8%	Shares	Other	2024-05-15
2023-12-31	$11,256,476	1,111,202	-49.4%	Shares	Other	2024-02-14
2023-09-30	$17,119,486	2,194,806	-22.7%	Shares	Other	2023-11-14
2023-06-30	$23,359,348	2,838,317	+11792.2%	Shares	Other	2023-08-14
2022-12-31	$211,700	23,867	+34.7%	Shares	Other	2023-02-14
2022-03-31	$337,129	17,725	-95.4%	Shares	Other	2022-05-16
2021-12-31	$10,264,946	386,627	—	Shares	Other	2022-02-14
No filing history on record for this holder in this stock.